MedTrace Logo

Impact of Preoperative Midazolam on Outcome of Elderly Patients

NCT03052660 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 782

Last updated 2019-11-18

No results posted yet for this study

Summary

We aim to assess, if placebo compared to preoperative administration of midazolam in elderly patients is equal in regard to the global postoperative patient satisfaction

Conditions

  • Preanesthetic Medication

Interventions

DRUG

Midazolam

Oral administration preoperatively

DRUG

Placebo oral capsule

Oral administration preoperatively

Sponsors & Collaborators

  • RWTH Aachen University

    lead OTHER

Principal Investigators

  • Mark Coburn, Professor · Department of Anesthesiology, University Hospital Aachen, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-12
Primary Completion
2019-06-24
Completion
2019-06-24

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03052660 on ClinicalTrials.gov